Clinical Trials Directory

Trials / Completed

CompletedNCT04695314

Foot Reflexology in Ocular Hypertensive and Glaucoma Patients

Effect of Foot Reflexology on Intraocular Pressure in Ocular Hypertensive and Glaucoma Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Temple University · Academic / Other
Sex
All
Age
30 Years – 90 Years
Healthy volunteers
Accepted

Summary

To determine the effect of foot reflexology in primary open angle glaucoma (POAG) patients and the effect of a shoe insert to perform continuous foot reflexology in ocular hypertensive (OHTN) patients.

Detailed description

This is a prospective pilot study in glaucoma patients and a prospective therapeutic trial in ocular hypertensive patients. Patients were recruited from the Temple Ophthalmology outpatient clinic. Primary open-angle glaucoma patients were recruited from those about to have SLT for additional intraocular pressure (IOP) lowering. OHTN patients were recruited from the clinic. The glaucoma patients performed a 5-minute foot massage on a foot massage board and the IOP was checked pre-massage, post-massage and 30, 60, 90 and 120 min post massage. OHTN patients underwent a one-month drop washout and then performed a 5-minute massage using a 3D-printed shoe insert with the identical pressure checks. They then were randomly assigned to wear the shoe insert or a sham insert for one day. IOP was checked before inserting the insert and at the end of the day. The number of steps was recorded each day.

Conditions

Interventions

TypeNameDescription
DEVICEMassageFoot reflexology board (JAPAN TSUBO HH-700) with massage focused at the base of the second and third toes
PROCEDUREExperimental insertRaised shoe insert, insert used for massage
PROCEDURESham insertFlat shoe insert, insert used for massage

Timeline

Start date
2017-11-07
Primary completion
2020-11-18
Completion
2020-11-18
First posted
2021-01-05
Last updated
2021-02-05

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04695314. Inclusion in this directory is not an endorsement.